Back
Prothena Corp. Plc 10K Form
Sell
41
PRTA
Prothena Corp. Plc
Last Price:
$11.15
Seasonality Move:
0%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2024-02-22 | 10K | PRTA/Prothena Corp. Plc Annual |
| 2023-11-02 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-08-03 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-05-04 | 10Q | PRTA/Prothena Corp. Plc Quarterly |
| 2023-02-28 | 10K | PRTA/Prothena Corp. Plc Annual |
Receive PRTA News And Ratings
See the #1 stock for the next 7 days that we like better than PRTA
PRTA Financial Statistics
Sales & Book Value
| Annual Sales: | $135.2M |
|---|---|
| Cash Flow: | $-43.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $5.48 |
| Price / Book: | 2.04 |
Profitability
| EPS (TTM): | -5.21060 |
|---|---|
| Net Income (TTM): | $-280.5M |
| Gross Margin: | $131.6M |
| Return on Equity: | -67.47% |
| Return on Assets: | -58.69% |
Prothena Corp. Plc Earnings Forecast
Key Prothena Corp. Plc Financial Ratios
-
The Gross Profit Margin over the past 15 years for PRTA is 97.35%.
-
The Selling, General & Administrative Expenses for PRTA have been equal to 49.72% of Gross Profit Margin.
-
The Research & Development expenses have been 164.64% of Revenue.
-
The Net Earning history of PRTA is -90.49% of Total Revenues.
-
Per Share Earnings over the last 15 years have been positive in 7 years.
Prothena Corp. Plc Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PRTA |
| CUSIP: | G72800 |
| Website: | prothena.com |
Debt
| Debt-to-Equity Ratio: | 0.03 |
|---|---|
| Current Ratio: | 6.61 |
| Quick Ratio: | 6.43 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 21.19 |
PRTA Technical Analysis vs Fundamental Analysis
Sell
41
Prothena Corp. Plc (PRTA)
is a Sell
Is Prothena Corp. Plc a Buy or a Sell?
-
Prothena Corp. Plc stock is rated a SellThe current Prothena Corp. Plc [PRTA] share price is $11.16. The Score for PRTA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.